Dimitrios Pectasides

10.3k total citations
227 papers, 6.1k citations indexed

About

Dimitrios Pectasides is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Dimitrios Pectasides has authored 227 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Oncology, 56 papers in Surgery and 56 papers in Molecular Biology. Recurrent topics in Dimitrios Pectasides's work include Ovarian cancer diagnosis and treatment (34 papers), HER2/EGFR in Cancer Research (30 papers) and Colorectal Cancer Treatments and Studies (29 papers). Dimitrios Pectasides is often cited by papers focused on Ovarian cancer diagnosis and treatment (34 papers), HER2/EGFR in Cancer Research (30 papers) and Colorectal Cancer Treatments and Studies (29 papers). Dimitrios Pectasides collaborates with scholars based in Greece, United States and Germany. Dimitrios Pectasides's co-authors include George Fountzilas, Theofanis Economopoulos, Eirini Pectasides, Gerasimos Aravantinos, Meletios Α. Dimopoulos, Dimitrios Bafaloukos, George Papaxoinis, Helen Gogas, Haralabos P. Kalofonos and Dimosthenis Skarlos and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Dimitrios Pectasides

222 papers receiving 5.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dimitrios Pectasides Greece	43	2.9k	1.7k	1.3k	1.2k	1.1k	227	6.1k
Claire F. Verschraegen United States	46	3.0k 1.0×	2.0k 1.2×	1.1k 0.8×	1.5k 1.2×	1.2k 1.1×	267	6.9k
Federica Tomao Italy	38	2.0k 0.7×	1.2k 0.7×	949 0.7×	1.0k 0.8×	1.1k 1.0×	243	4.9k
Aristotelis Bamias Greece	36	3.1k 1.0×	1.7k 1.0×	1.9k 1.5×	2.2k 1.8×	1.7k 1.5×	276	6.9k
Keiichi Fujiwara Japan	42	2.7k 0.9×	1.4k 0.8×	1.3k 1.0×	1.4k 1.2×	2.6k 2.4×	364	6.7k
Stephen A. Cannistra United States	30	1.9k 0.6×	2.0k 1.2×	611 0.5×	512 0.4×	2.0k 1.9×	46	5.1k
Joachim Diebold Germany	46	2.9k 1.0×	3.2k 1.9×	1.0k 0.8×	1.9k 1.5×	807 0.8×	224	8.1k
Antonio González-Martı́n Spain	40	4.1k 1.4×	1.4k 0.8×	1.1k 0.8×	1.1k 0.9×	3.5k 3.3×	307	7.5k
Walther Kuhn Germany	38	1.7k 0.6×	943 0.6×	977 0.7×	620 0.5×	1.5k 1.4×	118	5.7k
Ashley E. Winkler United States	10	3.9k 1.3×	1.1k 0.7×	1.4k 1.1×	2.5k 2.0×	322 0.3×	12	7.3k
Alexander Reinthaller Austria	46	2.2k 0.7×	1.3k 0.8×	2.1k 1.6×	895 0.7×	2.4k 2.2×	273	7.2k

Countries citing papers authored by Dimitrios Pectasides

Since Specialization

Citations

This map shows the geographic impact of Dimitrios Pectasides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitrios Pectasides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitrios Pectasides more than expected).

Fields of papers citing papers by Dimitrios Pectasides

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitrios Pectasides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitrios Pectasides. The network helps show where Dimitrios Pectasides may publish in the future.

Co-authorship network of co-authors of Dimitrios Pectasides

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitrios Pectasides. A scholar is included among the top collaborators of Dimitrios Pectasides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitrios Pectasides. Dimitrios Pectasides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Razis, Evangelia, Georgia-Angeliki Koliou, Eleftheria Tsolaki, et al.. (2021). Evaluation of the Role of p95 HER2 Isoform in Trastuzumab Efficacy in Metastatic Breast Cancer. Anticancer Research. 41(4). 1793–1802. 6 indexed citations

Linardou, Helena, G. Kouvatseas, Giannis Mountzios, et al.. (2019). Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment. Cancer Genomics & Proteomics. 16(6). 531–541. 11 indexed citations

Tsiatas, Marinos, Konstantine T. Kalogeras, Kyriaki Manousou, et al.. (2018). Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early‐stage breast cancer patients treated with anthracycline‐based adjuvant chemotherapy. Cancer Medicine. 7(10). 5066–5082. 8 indexed citations

Koutsoukos, Konstantinos, Kimon Tzannis, Christos Christodoulou, et al.. (2015). Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG). World Journal of Urology. 34(6). 853–857. 3 indexed citations

Koutras, Αngelos, Konstantine T. Kalogeras, Ralph M. Wirtz, et al.. (2015). Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study. Journal of Translational Medicine. 13(1). 171–171. 12 indexed citations

Linardou, Helena, Konstantine T. Kalogeras, Ralf Kronenwett, et al.. (2015). Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.. PubMed. 35(7). 4023–36. 6 indexed citations

Cohen, Stacey A., Chen Wu, Ming Yu, et al.. (2015). Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin. Clinical Colorectal Cancer. 15(2). 164–169. 26 indexed citations

Pavlakis, Kitty, Mattheos Bobos, Anna Batistatou, et al.. (2014). p85 Protein Expression is Associated with Poor Survival in HER2-Positive Patients with Advanced Breast Cancer Treated with Trastuzumab. Pathology & Oncology Research. 21(2). 273–282. 5 indexed citations

Fountzilas, George, Vassiliki Kotoula, Dimitrios Pectasides, et al.. (2013). Ixabepilone Administered Weekly or Every Three Weeks in HER2-Negative Metastatic Breast Cancer Patients; A Randomized Non-Comparative Phase II Trial. PLoS ONE. 8(7). e69256–e69256. 11 indexed citations

10.

Korantzis, Ippokratis, Konstantine T. Kalogeras, George Papaxoinis, et al.. (2012). Expression of angiogenic markers in the peripheral blood of patients with advanced breast cancer treated with weekly docetaxel.. PubMed. 32(10). 4569–80. 12 indexed citations

11.

Razis, Evangelia, Mattheos Bobos, Vassiliki Kotoula, et al.. (2011). Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer. Breast Cancer Research and Treatment. 128(2). 447–456. 137 indexed citations

12.

Bamias, Aristotelis, M. Karina, Pavlos Papakostas, et al.. (2010). A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer. Cancer Chemotherapy and Pharmacology. 65(6). 1009–1021. 75 indexed citations

13.

Psyrri, Amanda, Sotirios G. Papageorgiou, Andreas Scorilas, et al.. (2009). Phosphatidylinositol 3′-Kinase Catalytic Subunit α Gene Amplification Contributes to the Pathogenesis of Mantle Cell Lymphoma. Clinical Cancer Research. 15(18). 5724–5732. 86 indexed citations

14.

Koutras, Αngelos, Konstantine T. Kalogeras, Meletios Α. Dimopoulos, et al.. (2008). Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study. British Journal of Cancer. 99(11). 1775–1785. 53 indexed citations

15.

Gogas, Helen, J. Ioannovich, Urania Dafni, et al.. (2006). Prognostic Significance of Autoimmunity during Treatment of Melanoma with Interferon. New England Journal of Medicine. 354(7). 709–718. 428 indexed citations

16.

Mauri, Davide, George Pentheroudakis, D. Bafaloukos, et al.. (2006). Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data.. PubMed. 26(4B). 3175–81. 43 indexed citations

17.

Pectasides, Dimitrios, Petroula Arapantoni-Dadioti, Christos Valavanis, et al.. (2006). HER-2/neu status of primary breast cancer and corresponding metastatic sites in patients with advanced breast cancer treated with trastuzumab-based therapy.. PubMed. 26(1B). 647–53. 58 indexed citations

18.

Kosmas, Christos, et al.. (2005). Intramedullary spinal cord metastases in breast cancer: report of four cases and review of the literature. Journal of Neuro-Oncology. 71(1). 67–72. 30 indexed citations

19.

Pectasides, Dimitrios, et al.. (2000). Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial. European Journal of Cancer. 36(1). 74–79. 22 indexed citations

20.

Skarlos, D., Dimitrios Pectasides, N. Pavlidis, et al.. (1999). Weekly Alternating Non-Cross-Resistant Chemotherapy for Small Cell Lung Cancer With a Good Prognosis. American Journal of Clinical Oncology. 22(1). 87–93. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact